• home
  • search
  • contact
About Us
  • Corporate Overview
  • board of directors
  • scientific advisory board

Our molecular imaging agents are targeted to the pathological changes underlying chronic human diseases.

Advisor

John Zehner

Mr. Zehner has 14 years of experience in the Nuclear Medicine field. Mr. Zehner has been part of several start-ups, mergers and acquisitions. In 1993, he assisted in the start-up of Northern Virginia Isotopes, Inc., a nuclear pharmacy focused on distributing radioactive pharmaceuticals for diagnostics and therapy to the Washington D.C. market. In 1994, he established Valley Isotopes, Inc., a nuclear pharmacy in Winchester, Virginia, Inc. In 1995, John led the formation of Eastern Isotopes, Inc. through the merger of three nuclear pharmacies and later established its pharmaceutical manufacturing division for FDG in 1998. In 1999, he became President and COO of Eastern Isotopes, Inc. and under his leadership grew sales from approximately $4 million to over $34 million by 2003. In 2004, Mr. Zehner led the extremely lucrative sale of Eastern Isotopes, Inc. to IBA, SA, and a Belgium life science company.